Gwendolyn Wrenn Baxter

Array ( [id] => 6990481 [patent_doc_number] => 20050089518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Prospective identification and characterization of breast cancer stem cells' [patent_app_type] => utility [patent_app_number] => 10/497791 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11843 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089518.pdf [firstpage_image] =>[orig_patent_app_number] => 10497791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 466885 [patent_doc_number] => 07235380 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-06-26 [patent_title] => 'CDR-grafted anti-tissue factor antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/313392 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 12529 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235380.pdf [firstpage_image] =>[orig_patent_app_number] => 10313392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805578 [patent_doc_number] => 20030232972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Rationally designed antibodies' [patent_app_type] => new [patent_app_number] => 10/307724 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 23650 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232972.pdf [firstpage_image] =>[orig_patent_app_number] => 10307724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7143965 [patent_doc_number] => 20050118656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Methods for diagnosis and treatment of epithelial-derived cancers' [patent_app_type] => utility [patent_app_number] => 10/496892 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16069 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118656.pdf [firstpage_image] =>[orig_patent_app_number] => 10496892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486718 [patent_doc_number] => 07217795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'Tumor suppressor designated TS10q23.3' [patent_app_type] => utility [patent_app_number] => 10/299003 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 51 [patent_no_of_words] => 56298 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217795.pdf [firstpage_image] =>[orig_patent_app_number] => 10299003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6808699 [patent_doc_number] => 20030198638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Tumor specific monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 10/300675 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25760 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198638.pdf [firstpage_image] =>[orig_patent_app_number] => 10300675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642583 [patent_doc_number] => 20030103975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Modulation of angiogenesis and endothelialization' [patent_app_type] => new [patent_app_number] => 10/299058 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17375 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103975.pdf [firstpage_image] =>[orig_patent_app_number] => 10299058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682729 [patent_doc_number] => 20030118593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers' [patent_app_type] => new [patent_app_number] => 10/290703 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25380 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118593.pdf [firstpage_image] =>[orig_patent_app_number] => 10290703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683876 [patent_doc_number] => 20030119740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Compositions and methods for the diagnosis, prevention and treatment of tumor progression' [patent_app_type] => new [patent_app_number] => 10/281644 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35555 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119740.pdf [firstpage_image] =>[orig_patent_app_number] => 10281644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725480 [patent_doc_number] => 20030207792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Treating cancer' [patent_app_type] => new [patent_app_number] => 10/272301 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17253 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207792.pdf [firstpage_image] =>[orig_patent_app_number] => 10272301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788339 [patent_doc_number] => 20030139578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Antibodies specifically binding PDE8A and PDE8B' [patent_app_type] => new [patent_app_number] => 10/272970 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23800 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139578.pdf [firstpage_image] =>[orig_patent_app_number] => 10272970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683875 [patent_doc_number] => 20030119739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains' [patent_app_type] => new [patent_app_number] => 10/262589 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20053 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119739.pdf [firstpage_image] =>[orig_patent_app_number] => 10262589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880461 [patent_doc_number] => 07355012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells' [patent_app_type] => utility [patent_app_number] => 10/490535 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19444 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/355/07355012.pdf [firstpage_image] =>[orig_patent_app_number] => 10490535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220684 [patent_doc_number] => 20040072266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Method of modifying cell motility via compounds and polypeptides that interact with a Wnt pathway' [patent_app_type] => new [patent_app_number] => 10/251769 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11515 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072266.pdf [firstpage_image] =>[orig_patent_app_number] => 10251769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745061 [patent_doc_number] => 20030022244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Single chain antibody against mutant P53' [patent_app_type] => new [patent_app_number] => 10/247488 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9608 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022244.pdf [firstpage_image] =>[orig_patent_app_number] => 10247488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860498 [patent_doc_number] => 20030091506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Methods of using 22417, a novel human aminoprotease family member' [patent_app_type] => new [patent_app_number] => 10/245538 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 44887 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091506.pdf [firstpage_image] =>[orig_patent_app_number] => 10245538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6782622 [patent_doc_number] => 20030064069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Specific binding members for TGFbeta1' [patent_app_type] => new [patent_app_number] => 10/243308 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15725 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064069.pdf [firstpage_image] =>[orig_patent_app_number] => 10243308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860558 [patent_doc_number] => 20030091566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Specific binding members for TGFbeta1' [patent_app_type] => new [patent_app_number] => 10/243265 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15717 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091566.pdf [firstpage_image] =>[orig_patent_app_number] => 10243265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792065 [patent_doc_number] => 20030087409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Human lysyl hydroxylase-like protein' [patent_app_type] => new [patent_app_number] => 10/235521 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19033 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087409.pdf [firstpage_image] =>[orig_patent_app_number] => 10235521 [rel_patent_id] =>[rel_patent_doc_number] =>)